BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharmaconomics//FDA Catalyst Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
BEGIN:VEVENT
UID:pharmaconomics-629@pharmaconomics
DTSTAMP:20260707T040044Z
DTSTART;VALUE=DATE:20250701
DTEND;VALUE=DATE:20250702
SUMMARY:PROK AdCom — rilparencel (estimated date)
DESCRIPTION:An FDA advisory committee reviews rilparencel for chronic kidney disease (CKD) around ~ Jul 1\, 2025. The panel's public vote often front-runs the agency's final verdict — and the share price.\n\nPrimary source: https://www.sec.gov/Archives/edgar/data/1850270/000119312526225848/prok-ex99_1.htm\n\nTrack it: https://pharmaconomics.com/e/629
URL:https://pharmaconomics.com/e/629
TRANSP:TRANSPARENT
BEGIN:VALARM
TRIGGER:-P1D
ACTION:DISPLAY
DESCRIPTION:PROK catalyst tomorrow
END:VALARM
END:VEVENT
END:VCALENDAR